300+ investors in your industry, stage, and region Get
Any industry
Google
Biotech
Proptech
Climate
Artificial Intelligence
Impact
EdTech
Sustainability
Clean Energy
Retail
Finance
Digital Media
Local
Enterprise Software
Travel
Platforms
Recruiting
Social
Wine and Spirits
Mobile Apps
InsurTech
Oil and Gas
Theatre
Non Profit
Social Impact
Celebrity
Cryptocurrency
SaaS
Film
Crowdfunding
Venture Capital
Infrastructure
Restaurants
Sporting Goods
Fashion
LGBT
Photography
Payments
Renewable Energy
Organic Food
Email
Financial Services
Manufacturing
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Community
Hardware
Gaming
Media (Entertainment)
Facebook
Blockchain
Beauty
Real Estate
Life Science
B2B
Publishing
Food and Beverage
Social Network
Web3
Big Data
Video Games
Education
Medical
Wellness
Medical Device
Art
Social Media
Android
Internet
Franchise
Music
Mobile
Legal
Construction
Automotive
Sports
eSports
Hospitality
Cannabis
Mobile Advertising
Biotechnology
FinTech
Consumer
Transportation
Enterprise
Software
Any country
South Korea
Oceania
Asia
Brazil
Africa
Middle East
Europe
LATAM
Saudi Arabia
Singapore
Finland
Gibraltar
Greece
Norway
Israel
Italy
Lebanon
Liberia
Mexico
Tajikistan
Taiwan
Zimbabwe
Puerto Rico
Russian Federation
Sweden
San Marino
Togo
Tunisia
Zambia
Nigeria
Isle of Man
Mongolia
Pakistan
Romania
Oman
Colombia
Cameroon
Australia
India
New Zealand
China
Indonesia
Sri Lanka
Vietnam
Armenia
Austria
Barbados
Albania
Bangladesh
Belgium
Argentina
Bahrain
Costa Rica
Belarus
Belize
Chile
Switzerland
Czech Republic
Estonia
Algeria
Honduras
Iceland
Cambodia
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Slovenia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
Canada
United Kingdom
Ireland
Cyprus
Qatar
Spain
South Africa
United Arab Emirates
Azerbaijan
Bulgaria
Bolivia
Bermuda
Bahamas
Egypt
France
Georgia
Faroe Islands
Denmark
Dominican Republic
Ecuador
Croatia
Hong Kong
Ghana
Ethiopia
Grenada
Iraq
Hungary
Jordan
Jersey
Liechtenstein
Mali
Myanmar
Latvia
Morocco
Lithuania
Malaysia
Peru
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Thailand
El Salvador
Senegal
Tanzania
Uruguay
Ukraine
United States
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 20 Life Science Startup Investors in Singapore (June 2026)

The most active venture capital funds and angel investors investing in Singapore Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Singapore Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
EDBI
VC Fund
2 United States, Singapore, India Series C, Series B, Series D Biotechnology, Software, Health Care $10M–$400M
Eisai
VC Fund
2 Japan, United States, China Series A, Series C Biotechnology, Medical, Health Care $3M–$794M
Altara Ventures
VC Fund
1 Indonesia, Singapore, Philippines Series A, Series B, Seed FinTech, Software, Financial Services $2.1M–$40M
KT Investment
VC Fund
1 South Korea, United States, Singapore Series A, Series B, Series C Artificial Intelligence, Software, Information Technology $1.7M–$104M
Hana Financial Investment
VC Fund
1 South Korea, Singapore, India Series A, Series B, Seed Information Technology, Biotechnology, Software $860k–$25M
Nestle
VC Fund
1 United States, Germany, United Kingdom Grant, Private Equity Food and Beverage, Health Care, Food Processing $6k–$3.8B
Lightstone Ventures
VC Fund
1 United States, Ireland, Singapore Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
M Capital Partners
VC Fund
1 France, United States, Canada Seed, Series A Health Care, Software, Food and Beverage $1.1M–$7.7M
The Venture Collective
VC Fund
1 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Health Care, Biotechnology, Artificial Intelligence $410k–$33M
Anzu Partners
VC Fund
1 United States, Canada, Spain Series A, Series B Biotechnology, Software, Manufacturing $5M–$34M
K3 Ventures
VC Fund
1 Singapore, United States, Indonesia Series A, Seed Financial Services, FinTech, Software $1.2M–$42M
SK Securities
VC Fund
1 South Korea, United States, Singapore Series A, Seed, Series B Apps, Health Care, Information Technology $1k–$24M
Partners Investment
VC Fund
1 South Korea, United States, Japan Series B, Series A, Series C Biotechnology, Health Care, Software $1.5M–$98M
Amgen Ventures
VC Fund
1 United States, Canada, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $3.5M–$110M
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
1 Japan, United States, India Seed, Series A Health Care, Biotechnology, Medical $3.1M–$85M
Temasek Holdings
VC Fund
1 United States, China, India Series B, Series C, Series D Biotechnology, Health Care, Software $29M–$500M
Seeds Capital
VC Fund
1 Singapore, United States, Hong Kong Seed, Series A, Series B Software, Biotechnology, Health Care $767k–$45M
KB Financial Group
VC Fund
1 South Korea, India, Vietnam Series A, Series B, Seed Software, Financial Services, SaaS $1M–$104M
Openspace Capital
VC Fund
1 Singapore, Indonesia, Philippines Series A, Series B, Seed E-Commerce, Financial Services, Software $1.9M–$35M
Prox Ventures
VC Fund
1 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $1.9M–$28M
Access all 37 investors in Singapore Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

EDBI
VC Fund · Singapore, Central Region, Singapore · 2 investments in Singapore Life Science startups

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series C, Series B, Series D
  • Geography: United States, Singapore, India

Investor stats

  • Total investments: 185
  • Round size: Series B $19M–$200M; Series C $10M–$220M; Series D $17M–$400M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Paxata — The DataRobot End-of-Life (EOL) policy helps manage product lifecycle phases in a way that is transparent and clear for customers who will seamlessly transition to a new product or service.
  • Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
  • GoSecure (formerly CounterTack) — GoSecure is a recognized cybersecurity leader and innovator, pioneering the integration of endpoint, network, and email threat detection into a single Managed Extended Detection and Response (MXDR) service. For over 20 years, GoSecure has been helping customers better understand their security gaps and improve their organizational risk and securitymaturity through MXDR and Professional Services solutions delivered by one of the most trusted and skilled teams in the industry.
Show all investments...

Eisai
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Singapore Life Science startups

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series C
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 14
  • Round size: Series A $3M–$794M; Series C $46M–$100M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Seed Therapeutics — SEED Therapeutics designs molecular glue degraders using the full E3 ligase universe to eliminate disease proteins across oncology and beyond.
  • Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
  • Lifenet Insurance Company — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
Show all investments...

Altara Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Singapore-based venture firm backing Series A & B companies across Southeast Asia. Built by operators for founders who understand the long climb. Global perspective, local instincts.

Show more...

Investment focus

  • Industry: FinTech, Software, Financial Services
  • Stage:Series A, Series B, Seed
  • Geography: Indonesia, Singapore, Philippines

Investor stats

  • Total investments: 22
  • Round size: Seed $2.1M–$5M; Series A $4.5M–$13M; Series B $3.9M–$40M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Hyper Lounge — Hyperlounge is a startup that has developed a monthly subscription management analysis SaaS by combining management consulting know-how with data collection, analysis and visualization technology. It is a specialized system for small and medium-sized business executives, which is completely different from existing data analysis tools or services.When using this service, user can easily check the core data and analysis necessary for business management every day on mobile without the burden of initial investment or recruitment.
  • PolicyStreet — Renew your insurance and road tax instantly, hassle-free. We're the BEST, but don't just take our word for it. See what our happy customers have to say!
  • KYAN Therapeutics — KYAN Therapeutics is a clinical-stage artificial intelligence company leveraging its proprietary technology platforms to transform the way patients are treated and therapies are developed. KYAN is able to revolutionize the drug development and dosage optimization processes and has multiple pipeline combination therapies in development for oncologyand infectious diseases. KYAN de-risks and dramatically accelerates the drug development process, identifying novel combination therapies with unprecedented efficacy and safety. KYAN's clinically-validated platforms are uniquely disease-mechanism and indication agnostic.
Show all investments...

KT Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

KT Investment, established in 2015 as the venture capital arm of KT Group, is dedicated to driving social impact while achieving maximum investment returns. We stand with founders every step of the way, providing the support and resources necessary to transform innovative ideas into impactful ventures. By partnering with promising startups andventure companies, we create win-win opportunities that pave the way for long-term success. With a global perspective, we actively seek value-driven investments that shape the future.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 74
  • Round size: Series A $1.7M–$26M; Series B $5.9M–$104M; Series C $11M–$42M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Medipal — Medipal provides personal health for a health consultation. It provides subscription-based personal nurse service for patients.
  • MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
  • Twinny — Twinny specializes in the development of self-driving robots.
Show all investments...

Hana Financial Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Show more...

Investment focus

  • Industry: Information Technology, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, Singapore, India

Investor stats

  • Total investments: 90
  • Round size: Seed $860k–$7.9M; Series A $1.9M–$25M; Series B $1.6M–$25M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Trustay — Trustay is a real estate asset management company.
  • Kimu Studio — Kimu discovers servant artists, plans education and exhibitions with the artist's unique sensibility.
  • Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.
Show all investments...

Nestle
VC Fund · Vevey, Vaud, Switzerland · 1 investments in Singapore Life Science startups

Nestle manufactures and sells food and beverages for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestle, Nescafe, Perrier, Pure Life, and Purina. Nestle also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

Show more...

Investment focus

  • Industry: Food and Beverage, Health Care, Food Processing
  • Stage:Grant, Private Equity
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 18
  • Round size: Grant $6k–$150k; Private Equity $130M–$3.8B
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • Freshly — Our fully-prepared meals are delivered fresh and ready to eat. We can fuel your dietary preference: plant-based, gluten-free, low calorie, low carb, keto, paleo, and more.
  • Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
  • Hsu Fu Chi — Hsu Fu Chi is a confectionery company that manufactures various confectionaries, biscuits, chocolates, jellies, sachima, and snacks.
Show all investments...

Lightstone Ventures
VC Fund · Menlo Park, California, United States · 1 investments in Singapore Life Science startups

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland, Singapore

Investor stats

  • Total investments: 81
  • Round size: Series A $7M–$95M; Series B $18M–$100M; Series C $20M–$105M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Earlens — Earlens is the world's first and only hearing aid solution to directly vibrate the eardrum, delivering a more complete sound than any other hearing aid.
  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • Claret Medical — Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged duringvascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California.
Show all investments...

M Capital Partners
VC Fund · Toulouse, Midi-Pyrenees, France · 1 investments in Singapore Life Science startups

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Show more...

Investment focus

  • Industry: Health Care, Software, Food and Beverage
  • Stage:Seed, Series A
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 108
  • Round size: Seed $1.1M–$5.2M; Series A $3.3M–$7.7M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Hakbah — Hakbah is a Fintech startup focusing on an alternative financial saving. Hakbah is modernizing financial saving via its intelligent platform by offering a comprehensive one-stop-shop solution for Savings Groups to initiate, manage, join, and pay directly within the mobile app.
  • Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.
  • The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
Show all investments...

The Venture Collective
VC Fund · New York, New York, United States · 1 investments in Singapore Life Science startups

TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 50
  • Round size: Seed $2.7M–$20M; Pre-Seed $410k–$1.8M; Series A $7M–$33M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • SimpliFed — SimpliFed provides virtual breastfeeding and baby feeding support fully covered by your health plan from pregnancy to weaning.
  • Cocoon — Low carbon construction materials for the builders of tomorrow.
  • Unnatural Products — Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets. Its AI-enhanced technology platform creates entirely new drugs by engineering passively permeable, macrocyclic peptides that access traditionally undruggable targets.Unnatural Products was founded in 2017 and is headquartered in Santa Cruz,California.
Show all investments...

Anzu Partners
VC Fund · Washington, District of Columbia, United States · 1 investments in Singapore Life Science startups

Anzu Partners invests in breakthrough clean tech, industrial, and life science technologies with $1B in assets under management across venture, credit, and public structures.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Manufacturing
  • Stage:Series A, Series B
  • Geography: United States, Canada, Spain

Investor stats

  • Total investments: 75
  • Round size: Series A $5.3M–$25M; Series B $5M–$34M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: Likely still investing — raised $100M in 2024

Portfolio highlights

  • CytoTronics — CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.
  • ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
  • InterVenn — InterVenn focuses on the identification, quantification, and classification of Glycoproteomic and other PTM signals found in human blood and tissue for biomarker and target discovery. It specializes in the fields of biotechnology and life science. The company's VISTA is the first commercially available platform that can assess (serum orplasma) protein glycosylation in a site-specific manner, across thousands of peptides and glycopeptides.It was founded in 2017 and headquartered in Redwood City, California.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
K3 Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Series A, Seed
  • Geography: Singapore, United States, Indonesia

Investor stats

  • Total investments: 93
  • Round size: Seed $1.2M–$20M; Series A $2M–$42M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Abound — Fintern is a lending startup looking to offer an AI-driven alternative to costly payday loans. It aims to expand access to low-cost personal credit by using the UK’s new Open Banking standard to analyze consumers’ historical bank statement data. Open Banking data allows us to build a granular view of customers’ financial circumstances, properlyunderstand their affordability, and place less reliance on credit reference agency scores.The company was founded in 2020 and is based in London, United Kingdom.
  • Taranis — Taranis offers cutting-edge crop & farm management software for precision agriculture. Increase efficiency and yield. Learn more now.
  • Validus — Validus Group is the largest SME lending platform in South East Asia, operating in several countries across the region.
Show all investments...

SK Securities
VC Fund · Yongdungpo, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.

Show more...

Investment focus

  • Industry: Apps, Health Care, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 41
  • Round size: Seed $1k–$2.2M; Series A $3k–$24M; Series B $5k–$14M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • DSRV — Blockchain infrastructure company DSRV. Providing staking, custody, RPC nodes and Web3 solutions across 170+ protocols.
  • Kailos Lab — Kailos Lab is an AI-driven deep-tech company focused on materials research and development. It builds data and AI-powered platforms that accelerate the discovery, analysis, and development of new materials. By integrating computational models with laboratory data, the company aims to improve R&D efficiency and support innovation in advancedmaterials and industrial applications.
  • Soft Berry — Soft Berry is an electric vehicle charging platform.
Show all investments...

Partners Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 114
  • Round size: Series A $1.5M–$26M; Series B $5M–$98M; Series C $11M–$87M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Mustbio — MustBio is a biotechnology company that leverages multi-antibody technology to develop therapeutics primarily in the field of immuno-oncology. The company was founded in 2021 and is based in Seoul, South Korea.
  • Cenyx Biotech — Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
  • BOS Semiconductors — Driving the Future of Automotive, BOS Semiconductors
Show all investments...

Amgen Ventures
VC Fund · San Francisco, California, United States · 1 investments in Singapore Life Science startups

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 110
  • Round size: Series A $3.5M–$42M; Series B $11M–$110M; Series C $19M–$80M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2012

Portfolio highlights

  • Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.
  • Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
  • Mindset Medical — Mindset Medical is a Health Care Company that develops a platform for clinical information. Through their platform physicians will understand patient pain, saves time for providers and patients, they eliminate paper and redundant forms, and allows providers more time for patients. Mindset Medical was founded in 2016 in Phoenix, Arizona.
Show all investments...

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 1 investments in Singapore Life Science startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 172
  • Round size: Seed $3.1M–$54M; Series A $5.2M–$85M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • ALGO ARTIS — ALGO ARTIS is a software company that offers optimization in plant operations, tanking, ship allocation plan, and logistics.
  • SUN METALON — SUN METALON aims to create a world where metal products can be produced from local ores. The company was founded in 2021 and is headquartered in Redondo Beach, California.
  • BUGWORKS Research — Bugworks, a clinical stage biopharmaceutical company Harnessing the power of science to develop affordable, accessible, novel therapies against infectious disea
Show all investments...

Temasek Holdings
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series C, Series D
  • Geography: United States, China, India

Investor stats

  • Total investments: 395
  • Round size: Series B $29M–$300M; Series C $35M–$500M; Series D $45M–$450M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Glympse Bio — Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
  • Impossible Foods — Impossible Foods focuses on developing plant-based substitutes for meat, dairy, and fish products. It selects specific proteins and nutrients from greens, seeds, and grains to recreate the experience of meats and dairy products. Founded by Patrick Brown and Monte Casino in 2011, Impossible Foods is headquartered in Redwood City, California.
  • LeapFrog Investments — Scaling purpose-driven businesses to achieve leaps of growth, profitability and impact.
Show all investments...

Seeds Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Catalysing smart monies into Singapore-based, early-stage technology startups.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Singapore, United States, Hong Kong

Investor stats

  • Total investments: 121
  • Round size: Seed $767k–$5.2M; Series A $3.5M–$24M; Series B $5M–$45M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Datakrew — Datakrew delivers real-time EV battery analytics and AI-powered fleet intelligence. Smarter, safer fleets start here. Explore our solutions.
  • Atomionics — Atomionics is building atomic sensors for navigation and resource exploration. Sensing technology is severely inadequate for a lot of applications navigation and positioning, pinpointing oil and gas reserves, tunnel detection etc. Atomionics builds atomic sensors harnessing quantum mechanical properties of the atoms. This enables measurement ofparameters like gravity, acceleration and rotation with 1000x higher precision and accuracy than the current state of the art, leading to a completely new way of global positioning, and resource exploration.
  • Brano Therapeutics — Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases.
Show all investments...

KB Financial Group
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.

Show more...

Investment focus

  • Industry: Software, Financial Services, SaaS
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, India, Vietnam

Investor stats

  • Total investments: 12
  • Round size: Series A $1M–$45M; Series B $7.4M–$104M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
  • Wavebridge — Wavebridge is a top institutional digital asset company with traditional financial knowhows and crypto finance technology. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
  • BlockOdyssey — BlockOdyssey is a tech start-up that provides 'blockchain-based B2B solutions'.Currently, the main solution is supplying 'blockchain-based anti-counterfeiting solution', and logistics & distribution history management is in progress with blockchain. It has received investment from Asia's largest cosmetic company, andis conducting business with French pharmaceutical companies.
Show all investments...

Openspace Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Software
  • Stage:Series A, Series B, Seed
  • Geography: Singapore, Indonesia, Philippines

Investor stats

  • Total investments: 122
  • Round size: Seed $2.6M–$13M; Series A $1.9M–$20M; Series B $10M–$35M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Igloo — As a top insurtech company, Igloo makes insurance easy across Southeast Asia by working with reputable insurers and distribution partners.
  • Octopus — Integrated Reseller System Fully Automated
  • Kumu Holdings — kumu is a pinoy community platform where you can just hang out, explore the many livestreams the Kumunity has to offer, meet and chat with fellow Filipinos all around the world
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Singapore Life Science startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 72
  • Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
  • Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
  • Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Show all investments...

Life Science Investor funding in Singapore at a glance

Stats across 22 deals from 37 investors.

37
investors
in Singapore Life Science startups
22
deals
in Singapore Life Science startups
$14M
median round
in Singapore Life Science startups
54%
lead investors
lead at least one round
18%
Series A
most common funding stage
97/3
VC / Angel
share of investor count

Access all 37 investors in Singapore Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 37 investors investing in Singapore Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists